Axs Investments LLC Bristol Myers Squibb CO Transaction History

Axs Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 16, 2024	BUY	$47.98 - $54.4 $1.17 Million - $1.32 Million	24,325 New	24,325 $1.32 Million
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $46,684 - $52,931	-973 Reduced 3.85%	24,325 $1.32 Million
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $246,666 - $294,340	5,088 Added 25.18%	25,298 $1.3 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $102,060 - $114,118	1,763 Added 9.56%	20,210 $1.17 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $90,786 - $100,804	1,425 Added 8.37%	18,447 $1.18 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $155,666 - $176,561	2,369 Added 16.17%	17,022 $1.18 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $12,394 - $14,677	181 Added 1.25%	14,653 $1.05 Million
Q3 2022 Nov 07, 2022	BUY	$0.13 - $76.84 $101 - $60,012	781 Added 5.7%	14,472 $1.03 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $994,240 - $1.1 Million	13,691 New	13,691 $1.05 Million

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Axs Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Axs Investments LLC with notifications on news.